CLASS-I-INDUCED RESISTANCE TO NATURAL KILLING - IDENTIFICATION OF NONPERMISSIVE RESIDUES IN HLA-A2

被引:157
作者
STORKUS, WJ
SALTER, RD
ALEXANDER, J
WARD, FE
RUIZ, RE
CRESSWELL, P
DAWSON, JR
机构
[1] DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,BOX 3010,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT BIOL ANTHROPOL & ANAT,DURHAM,NC 27710
[3] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
关键词
TRANSFECTION; SITE-DIRECTED MUTAGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN-BINDING GROOVE;
D O I
10.1073/pnas.88.14.5989
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Structural characteristics of major histocompatibility complex class I antigens associated with natural killer (NK)-resistance phenomena were examined. Previous research has shown that transfection of class I genomic DNA clones into class 1-deficient, NK-sensitive target cell lines results in transfectants exhibiting class I+, NK-resistant phenotypes. In contrast to the HLA-A3, -B7, -B27, and -Bw58 class I molecules, the HLA-A2 class I molecules were shown not to protect target cells from NK activity. Here we show that this nonprotective phenotype maps to the alpha-1 domain of the HLA-A2 molecule by examining the NK-protective capacity of the natural interdomain recombinant HLA-Aw69 molecule. HLA-Aw69, which consists of an alpha-1 domain exhibiting homology with HLA-Aw68, and alpha-2/alpha-3/transmembrane-cytoplasmic domains, exhibiting homologies with HLA-A2, mimics HLA-Aw68 and provides HLA-A,B null target cell (C1R) transfectants with increased resistance to NK. Further, the inability of transfected HLA-A2 to confer protection against NK activity can be completely attributed to the expression of a "nonpermissive" residue at position 74 in the alpha-1 domain. Site-directed mutation of the His-74 residue in HLA-A2 to the Asp-74 (HLA-A3, -Aw68, -Aw69, -B7, and -B27) residue generates a mutant that provides CIR cell line transfectants an NK-resistant phenotype. As His-74 blocks access to a side pocket in the HLA-A2 antigen-binding cleft, these results support the critical involvement of residues within the peptide-binding groove of class I molecules in determining the NK susceptibility phenotype of class I+ target cells.
引用
收藏
页码:5989 / 5992
页数:4
相关论文
共 43 条
  • [1] THE T-CELL ANTIGEN RECEPTOR GAMMA-GENE - REARRANGEMENT AND CELL LINEAGES
    ALLISON, JP
    LANIER, LL
    [J]. IMMUNOLOGY TODAY, 1987, 8 (10): : 293 - 296
  • [2] AMOS DB, 1980, MANUAL CLIN IMMUNOLO, P978
  • [3] IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE
    ANDERSSON, M
    PAABO, S
    NILSSON, T
    PETERSON, PA
    [J]. CELL, 1985, 43 (01) : 215 - 222
  • [4] STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 506 - 512
  • [5] THE FOREIGN ANTIGEN-BINDING SITE AND T-CELL RECOGNITION REGIONS OF CLASS-I HISTOCOMPATIBILITY ANTIGENS
    BJORKMAN, PJ
    SAPER, MA
    SAMRAOUI, B
    BENNETT, WS
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1987, 329 (6139) : 512 - 518
  • [6] CLASS-I (H-2KB) GENE TRANSFECTION REDUCES SUSCEPTIBILITY OF YAC-1 LYMPHOMA TARGETS TO NATURAL-KILLER-CELLS
    CARLOW, DA
    PAYNE, U
    HOZUMI, N
    RODER, JC
    CZITROM, AA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (04) : 841 - 846
  • [7] DIFFERENTIAL EXPRESSION OF THE HLA-DR GENES IN VARIOUS MELANOMA CELL-LINES TREATED WITH INTERFERON-GAMMA - METHYLATION OF THE HLA-DR-ALPHA GENE IN THESE LINES IS NOT CORRELATED WITH ITS EXPRESSION
    CARRINGTON, MN
    CHEDID, M
    TING, JPY
    WARD, FE
    [J]. HUMAN IMMUNOLOGY, 1987, 18 (02) : 151 - 161
  • [8] INSITU DETECTION OF MYCOPLASMA CONTAMINATION IN CELL-CULTURES BY FLUORESCENT HOECHST-33258 STAIN
    CHEN, TR
    [J]. EXPERIMENTAL CELL RESEARCH, 1977, 104 (02) : 255 - 262
  • [9] IMMUNOLOGICAL SURVEILLANCE OF TUMORS IN THE CONTEXT OF MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION OF T-CELL FUNCTION
    DOHERTY, PC
    KNOWLES, BB
    WETTSTEIN, PJ
    [J]. ADVANCES IN CANCER RESEARCH, 1984, 42 : 1 - 65
  • [10] ENNIS PD, 1988, J IMMUNOL, V141, P642